Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease
Clinical trial NCT06293365 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06293365
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-02
- Primary completion
- 2026-02-17
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.